Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

13.61 +0.08 (+0.59%)
Delayed Quote Updated: 2:55 PM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Bioventus Reports Second Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
From Bioventus, Inc.
Via GlobeNewswire
News headline image
A Preview Of Bioventus's Earnings ↗
 
Via Benzinga
News headline image
Earnings Preview: Bioventus ↗
 
Via Benzinga
News headline image
3 Stocks Under $10 With Mammoth Growth Prospects ↗
Learn more about the growth stocks under $10 with progressive fundamentals in the healthcare and technology sectors. 
Via InvestorPlace
News headline image
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday! 
Via InvestorPlace
News headline image
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings ↗
 
Via Benzinga
News headline image
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q1 2024 ↗
BVS stock results show that Bioventus beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Bioventus Reports First Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. (NASDAQ: BLND) rose sharply during Friday’s session after the company reported... 
Via Benzinga
Topics Stocks
News headline image
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. 
Via Benzinga
News headline image
Bioventus Reports Upbeat Earnings, Joins Ranpak, Beachbody And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks were higher, with the Dow Jones index surging more than 200 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 12, 2024 ↗
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. 
Via Benzinga
News headline image
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
From Bioventus, Inc.
Via GlobeNewswire
News headline image
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
Bioventus Names Robert Claypoole as President and Chief Executive Officer
Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Revenue and Operating Margin Growth 
From Bioventus, Inc.
Via GlobeNewswire
News headline image
MedTech Bioventus' Stabilization Sparks Analyst Confidence, Earns Upgrade And Price Target Boost ↗
Canaccord Genuity has upgraded Biomedical Devices and Services company Bioventus Inc (NASDAQ: BVS), highlighting greater insight into the progress of the turnaround and plans for future investment and... 
Via Benzinga
News headline image
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.